2Z5X | A:23-460 | CRYSTAL STRUCTURE OF HUMAN MONOAMINE OXIDASE A WITH HARMINE |
2Z5Y | A:23-460 | CRYSTAL STRUCTURE OF HUMAN MONOAMINE OXIDASE A (G110A) WITH HARMINE |
1OJ9 | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE |
1OJA | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN |
1OJC | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE |
1OJD | L:14-451; L:14-451; L:14-451; L:14-451; L:14-451; L:14-451; L:14-451; L:14-451; L:14-451; L:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N-OXIDE (LDAO) |
1S2Q | B:14-451; B:14-451 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE) |
1S2Y | B:14-451; B:14-451 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)-AMINOINDAN |
1S3B | B:14-451; B:14-451 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)-AMINOINDAN |
1S3E | B:14-451; B:14-451 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN |
2V5Z | B:14-451; B:14-451 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR SAFINAMIDE |
2V60 | B:14-451; B:14-451 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY)-4-CARBOXALDEHYDE-COUMARIN |
2V61 | B:14-451; B:14-451 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY)-4-(METHYLAMINO)METHYL-COUMARIN |
2VRL | B:14-451; B:14-451 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE |
2VRM | B:14-451; B:14-451 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE |
2VZ2 | B:14-451; B:14-451 | HUMAN MAO B IN COMPLEX WITH MOFEGILINE |
2XCG | B:14-451; B:14-451 | TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE |
2XFN | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL) -2-IMIDAZOLINE |
2XFO | B:14-451; B:14-451 | TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B ILE199ALA MUTANT IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE |
2XFP | B:14-451; B:14-451 | ISATIN-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE |
2XFQ | B:14-451; B:14-451 | RASAGILINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE |
2XFU | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B WITH TRANYLCYPROMINE |
3PO7 | B:14-451; B:14-451 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ZONISAMIDE |
2UXN | A:288-826 | STRUCTURAL BASIS OF HISTONE DEMETHYLATION BY LSD1 REVEALED BY SUICIDE INACTIVATION |
2UXX | A:288-826 | HUMAN LSD1 HISTONE DEMETHYLASE-COREST IN COMPLEX WITH AN FAD-TRANYLCYPROMINE ADDUCT |
2V1D | A:288-826 | STRUCTURAL BASIS OF LSD1-COREST SELECTIVITY IN HISTONE H3 RECOGNITION |
2X0L | A:288-826 | CRYSTAL STRUCTURE OF A NEURO-SPECIFIC SPLICING VARIANT OF HUMAN HISTONE LYSINE DEMETHYLASE LSD1. |
2XAF | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH PARA-BROMO-(+)-CIS-2-PHENYLCYCLOPROPYL-1-AMINE |
2XAG | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH PARA-BROMO-(-)-TRANS-2-PHENYLCYCLOPROPYL-1-AMINE |
2XAH | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH (+)-TRANS-2-PHENYLCYCLOPROPYL-1-AMINE |
2XAJ | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH (-)-TRANS-2-PHENYLCYCLOPROPYL-1-AMINE |
2XAQ | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH A TRANYLCYPROMINE DERIVATIVE (MC2584, 13B) |
2XAS | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH A TRANYLCYPROMINE DERIVATIVE (MC2580, 14E) |
2Y48 | A:288-826 | CRYSTAL STRUCTURE OF LSD1-COREST IN COMPLEX WITH A N-TERMINAL SNAIL PEPTIDE |
2Z3Y | A:288-826 | CRYSTAL STRUCTURE OF LYSINE-SPECIFIC DEMETHYLASE1 |
2Z5U | A:288-826 | CRYSTAL STRUCTURE OF LYSINE-SPECIFIC HISTONE DEMETHYLASE 1 |
3NKS | A:12-471 | STRUCTURE OF HUMAN PROTOPORPHYRINOGEN IX OXIDASE |